Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • January 2018
  • Article
  • Clinical Pharmacology & Therapeutics

Innovation Incentives and Biomarkers

By: Ariel Dora Stern, Brian M. Alexander and Amitabh Chandra
  • Format:Print
  • | Pages:3
ShareBar

Abstract

Previously, we have discussed the importance of economic incentives in shaping markets for precision medicines. Here we consider incentives for biomarker development, including discovery and establishment. Biomarkers can reveal valuable information regarding diagnosis and prognosis, predict treatment efficacy or toxicity, serve as markers of disease progression, and serve as auxiliary endpoints for clinical trials. Some have multiple uses, while others have a specialized role, resulting in diverse incentives across players in the healthcare system.

Keywords

Health Care and Treatment; Innovation and Invention; Research and Development; Markets

Citation

Stern, Ariel Dora, Brian M. Alexander, and Amitabh Chandra. "Innovation Incentives and Biomarkers." Clinical Pharmacology & Therapeutics 103, no. 1 (January 2018): 34–36.
  • Find it at Harvard
  • Purchase

About The Author

Amitabh Chandra

Technology and Operations Management
→More Publications

More from the Authors

    • 2025
    • Faculty Research

    Expert Patients’ Use of Avoidable Health Care

    By: Amitabh Chandra, Pragya Kakani and Simone Matecna
    • November 2024
    • Quarterly Journal of Economics

    The Health Costs of Cost Sharing

    By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
    • October 2024
    • Health Affairs

    Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates

    By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini
More from the Authors
  • Expert Patients’ Use of Avoidable Health Care By: Amitabh Chandra, Pragya Kakani and Simone Matecna
  • The Health Costs of Cost Sharing By: Amitabh Chandra, Evan Flack and Ziad Obermeyer
  • Medicare Part D Protected-Class Policy Is Associated with Lower Drug Rebates By: Pragya Kakani, Michael Anne Kyle, Amitabh Chandra and Luca Maini
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.